Phosphorylase Activity Research Articles

Insight into invitro thymidine phosphorylase and in silico molecular docking studies: identification of hybrid thiazole bearing Schiff base derivatives.

In pursuit of effective thymidine phosphorylase inhibitors, a series of hybrid analogs of thiazole-hydrazone derivatives (1-15) were synthesized and evaluated for theirenzyme inhibitory potential using 7-deazaxanthine asapositive control. The goal was to determine these derivatives' effectiveness in suppressing thymidine phosphorylase activity, a target relevant to antitumor strategies due to the enzyme's role in angiogenesis and tumor growth. Biological evaluations indicated that all synthesized analogs displayed significant to moderate inhibitory activity, with IC50 values between 3.93±0.90 and 25.75±4.30 µM. Particularly, compounds 12, 9, and 28 exhibited superior potency, with IC50 values of 3.93±0.90, 4.10±1.10, and 4.50±1.10 µM, respectively, surpassing the standard inhibitor 7-deazaxanthine (IC50=16.8±2.20 µM). Additionally, molecular docking studies were performed to elucidate the binding interactions of the synthesized thiazole-hydrazone derivatives with the active site of thymidine phosphorylase. The docking results aligned well with experimental data, revealing favorable binding conformations and significant interactions that support the observed inhibitory activities, particularly in the most potent compounds. These findings underscore the promise of thiazole-hydrazone derivatives aseffective thymidine phosphorylase inhibitors, suggesting that targeted structural modifications could further enhance their activity. Further investigations, including invivo studies, are warranted to explore their potential applications in anticancer therapies. This study highlights the valuable role of molecular docking in understanding the structure-activity relationship (SAR) of thiazole-hydrazone derivatives, emphasizing the potential of these compounds in advancing thymidine phosphorylase inhibition strategies for therapeutic purposes.

Metabolic adaptation mechanisms of glycogen reduction and lipid accumulation in testicular protection in Daurian ground squirrels during hibernation.

The role of glycogen and lipid metabolism in the testes of Daurian ground squirrels (Spermophilus dauricus) during different stages of the hibernation cycle and their influence on reproductive function remain poorly understood. This study examined testicular morphology across hibernation stages and investigated potential molecular mechanisms. Results showed that: (1) Spermatocyte density was reduced in the torpor group compared to the pre-hibernation (PRE) group, suggesting a suppression of spermatogenesis during torpor. In the post-hibernation (POST) group, reduced spermatocyte density was speculated to correspond to the initial phase of spermatocyte maturation into spermatozoa. (2) Glycogen content was lower during interbout arousal (IBA), while glycogen phosphorylase (GP) activity was significantly elevated compared to the other stages. Sertoli cell density was higher in the IBA group relative to the torpor group, suggesting that elevated GP activity facilitates glycogen breakdown, providing glycolytic substrates for Sertoli cells during this phase. (3) During torpor, triglyceride and fatty acid levels, along with fatty acid synthase and acetyl-CoA carboxylase activities, remained consistent with PRE levels. These findings suggest that fatty acids are crucial for maintaining testicular reproductive function during torpor. In contrast, lipid metabolism indicators declined during the near post-hibernation (NP) and POST stages, likely supporting the rapid reactivation of reproductive processes required for the upcoming breeding season. In summary, this study highlights a dynamic interplay between lipid and glycogen metabolism across hibernation stages, with the transition from lipid-based metabolism during torpor to glycogen utilization during IBA playing a pivotal role in sustaining testicular homeostasis in Daurian ground squirrels.

P0073 Evaluation of PYGL as a Biomarker and Therapeutic Target in Ulcerative Colitis

Abstract Background Inflammation begins when innate immune cells recognize and respond to infections or tissue injuries to protect the body. In particular, cells such as macrophages and dendritic cells require more energy to manage these conditions. Glycogen metabolism is a crucial function for cells recruited to the site of inflammation to obtain energy. Within that process, glycogen phosphorylase plays a pivotal role as an enzyme for glycogenolysis. Because ulcerative colitis (UC) is a long-term condition in which the colon and rectum become inflamed, patients with the disease might have high levels of protein or activity of glycogen phosphorylase (PYGL) in the blood. Therefore, this study aims to identify the protein level and activity of PYGL in the serum and peripheral blood mononuclear cells (PBMC) of ulcerative colitis patients. Methods After blood from UC patients was provided by Daejeon St. Mary's Hospital, the PBMCs were isolated using Leucosep tube pre-filled with separation medium (Greiner bio-one, 163288), and the serum was isolated by centrifugation at 1000 x g for 10 minutes in a refrigerated centrifuge (Labogene, 1248R). The PBMCs were stored in an LN2 cell storage tank (ICBiomedical, LS6000), and the serum was stored in a deep freezer (Nihon freezer, CLN-52UW) at -80°C until samples of 60 patients were gathered. To compare with UC patients, normal human PBMCs (STEMCELL Technologies, 70025.1) were used. PYGL levels in serum and PBMCs from normal and UC patients were measured using Human PYGL ELISA Kit (Colorimetric) (Novus, NBP2-82520). PYGL activity in serum and PBMCs from normal and UC patients were measured using Glycogen phosphorylase activity assay kit (Colorimetric) (Abcam, ab273271). Activity Vmax and level from serum and PBMCs were analyzed using an unpaired t-test to determine significant differences (p < 0.05), fitting the standard. Activity reaction curve from serum and PBMCs was anlyzed using an mutiple unpaired t-test to determine significant differences (q < 0.05). GraphPad Prism 10 software was used for all analysis and the data were presented as Mean and SEM. Results Significant differences in PYGL activity were observed between UC patients and healthy controls in both serum and PBMC samples, though PYGL levels did not exhibit notable variation. These findings support the hypothesis that PYGL activity is linked to UC pathology and may serve as a marker for disease severity and progression. Conclusion This study provides initial evidence that PYGL activity could be a predictive biomarker and therapeutic target in UC. Future studies are warranted to further elucidate its role and assess the potential of PYGL inhibitors as a treatment strategy for autoimmune and inflammatory conditions like UC. References Ji Q, Li H, Cai Z, Yuan X et al. Share PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Int J Biol Sci. 2023 Mar 21;19(6):1894-1909. Ma J, Wei K, Liu J et al. Glycogen metabolism regulates macrophage-mediated acute inflammatory responses. Nat Commun. 2020 Apr 14;11(1):1769. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS. Glycogen and its metabolism: some new developments and old themes. Biochem J. 2012 Feb 1;441(3):763-87. Thwe PM, Pelgrom LR, Cooper R et al. Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses. Cell Metab. 2019 Jul 2;30(1):225.

Effects of Acute Aerobic Exercise on Skeletal Muscle and Liver Glucose Metabolism in Male Rodents with Type 1 Diabetes.

Aerobic exercise (AE) is associated with a significant hypoglycemia risk in individuals with type 1 diabetes mellitus (T1DM). However, the mechanisms in the liver and skeletal muscle governing exercise-induced hypoglycemia in T1DM are poorly understood. This study examined the effects of a 60-minute bout of AE on hepatic and muscle glucose metabolism in T1DM rats. Nineteen male Sprague-Dawley rats were divided into sedentary (SC; n=5) and T1DM (DSC; n=14) groups. T1DM rats were subcategorized into pre-exercise (DPRE; n=6) and post-exercise (DPOST; n=8). DPOST were sacrificed immediately after 60-minute of AE. Results demonstrate that DPOST animals experienced reductions in BG following 30 and 60 minutes of AE compared to pre-exercise. Both DPRE and DPOST animals exhibited lower hepatic glycogen content, while muscle glycogen did not differ, suggesting impaired glycogenolysis in T1DM. Hepatic glycogen-6-phosphatase content, and muscle and hepatic protein kinase B phosphorylation were significantly greater in DPOST animals, suggesting elevated gluconeogenesis and insulin stimulation during exercise. Glycogen phosphorylase activity did not differ between groups. These data suggest that drops in BG during AE in T1DM were due to lower glycogen levels in the liver and muscle and a lack of muscle glycogen utilization; leading to a reliance on gluconeogenesis and BG.

Mitochondrial Redox Status Regulates Glycogen Metabolism via Glycogen Phosphorylase Activity.

Mitochondria and glycogen are co-distributed in skeletal muscles to regulate the metabolic status. Mitochondria are also redox centers that regulate the muscle function during exercise. However, the pathophysiological relationship between the mitochondrial redox status and glycogen metabolism in the muscle remains unclear. In the present study, we examined the pathological effects of mitochondrial dysfunction induced by mitochondrial superoxide dismutase (SOD2) depletion on glycogen metabolism. We found that muscle glycogen was significantly accumulated in association with motor dysfunction in mice with a muscle-specific SOD2 deficiency. Muscle glycogen phosphorylase (GP-M) activity, which is a key enzyme for glycogen degradation at times when energy is needed (e.g., during exercise), was significantly decreased in the mutant muscle. Moreover, the GP-M activity on normal muscle sections decreased after treatment with paraquat, a superoxide generator. In contrast, treatment with antioxidants reversed the GP-M activity and motor disturbance of the mutant mice, indicating that GP-M activity was reversibly regulated by the redox balance. These results demonstrate that the maintenance of the mitochondrial redox balance regulates glycogen metabolism via GP-M activity.

Glycogen Supplementation in Vitro Promotes pH Decline in Dark-Cutting Beef by Reverting Muscle's Metabolome toward a Normal Postmortem Muscle State.

Dysregulated muscle glycogen metabolism preslaughter contributes to aberrant postmortem muscle pH (>5.8) in dark-cutting beef phenotypes. However, the underlying mechanisms have remained elusive. Herein, we examine the glycogen dependent regulation of postmortem muscle pH decline and darkening in beef. We show that supplementation of glycogen in vitro restores postmortem pH decline in dark-cutting beef by reverting the metabolome toward a typical postmortem muscle state characterized by increased activities of enzymes glycogen phosphorylase and lactate dehydrogenase (p < 0.05) coupled with a pronounced abundance of glycolytic metabolites and reduced abundance of tricarboxylic acid cycle and amino acid metabolites. Furthermore, concurrent inhibition of mitochondrial respiration at complexes I, IV, and V with glycogen supplementation stimulates greater pH decline. Together, our findings show that supplementing glycogen at low concentrations (10 mM) can reprogram the dark-cutting beef muscle's metabolome toward typical postmortem state and promote muscle acidification. Thus, enhancing glycogen levels could represent a promising strategy for mitigating dark-cutting beef phenotypes and improving meat quality.

Adaptations in hepatic glucose metabolism after chronic social defeat stress in mice

Chronic stress has been shown to induce hyperglycemia in both peripheral blood and the brain, yet the detailed mechanisms of glucose metabolism under stress remain unclear. Utilizing 13C6-labeled glucose to trace metabolic pathways, our study investigated the impact of stress by chronic social defeat (CSD) on glucose metabolites in the liver and brain one week post-stress. We observed a reduction in 13C6-enrichment of glucose metabolites in the liver, contrasting with unchanged levels in the brain. Notably, hepatic glycogen levels were reduced while lactate concentrations were elevated, suggesting lactate as an alternative energy source during stress. Long-term effects were also examined, revealing normalized blood glucose levels and restored glycogen stores in the liver three weeks post-CSD, despite sustained increases in food intake. This normalization is hypothesized to result from diminished glucagon levels leading to reduced glycogen phosphorylase activity. Our findings highlight a temporal shift in glucose metabolism, with hyperglycemia and glycogen depletion in the liver early after CSD, followed by a later phase of metabolic stabilization. These results underscore the liver’s critical role in adapting to CSD and provide insights into the metabolic adjustments that maintain glucose homeostasis under prolonged stress conditions.

Ethiopian coffee (Coffea arabica) improves glucose uptake and modulates metabolic enzyme activities linked to hyperglycemia-induced infertility in isolated rats’ testes

The present study evaluated the inhibitory effect of Ethiopian coffee (Coffea arabica) on carbohydrate digestive enzymes and its protective effect against glucose-induced testicular dysfunction using in vitro and in silico study models. Testicular oxidative stress was initiated by co-incubating testocular tissue collected from male Sprague-Dawley rats in glucose solution with different concentrations of Ethiopian coffee aqueous extracts (hot and cold) for 2 h at 37ºC. Glucose-mediated oxidative stress significantly (p < 0.05) depleted reduced glutathione and total glycogen levels while it lowered catalase and superoxide dismutase (SOD) activities in the testicular tissue. Concomitantly, this led to elevated malondialdehyde and nitric oxide levels while it also increased glycogen phosphorylase, fructose-1,6-bisphosphatase, ATPase, and acetylcholinesterase activities. Treatment with different concentrations of coffee aqueous extracts restored the enzymes’ and markers’ levels and activities. Although both the cold and hot coffee extracts strongly inhibited α-glucosidase and α-amylase enzymes, the former showed better activities. The subjection of the coffee extracts to LC-MS analysis indicated the presence of several compounds, including chlorogenic acid, caffeic acid, cafestol, kahweol, caffeine, quinic acid, ferulic acid, and catechol which were further docked with the carbohydrate digestive enzymes. The in silico results displayed that among the various metabolites, chlorogenic acid strongly interacted and had the best binding affinity with α-glucosidase and α-amylase. Our findings implied that Ethiopian coffee may have a preventive effect against glucose-induced testicular damage. These are evidenced by the capacity of the plant product to decrease oxidative stress and protect against testicular dysfunction.Graphical

Effect of Partial Knockout of the Plastid Starch Phosphorylase Gene NtPHO1-L1 on the Metabolism of Carbohydrates and Carotenoids in Nicotiana tabacum L. Leaves

Starch metabolism is regulated by a complex catalytic network, one of the key enzymes of which is the plastid starch phosphorylase PHO1. In this study, using the CRISPR-Cas9 system, we obtained tobacco (Nicotiana tabacum L.) plants with a partial knockout of the NtPHO1-L1 gene due to deletion variants of the catalytic domain of the NtPHO1-L1 protein, leading to the formation of nonfunctional forms of the enzyme. The edited lines differed from wild-type plants by increased starch accumulation and decreased content of sugars, chlorophylls, and carotenoids in the leaves. It was shown that, compared to the control, the edited plants were characterized by differential expression of starch (NtPHO1-L1, NtGWD, NtBAM1, NtBAM9, NtAI) and carotenoid (NtPSY2, NtPDS, NtZDS, NtCRTISO, NtVDE) metabolism genes, as well as genes encoding MADS-domain transcription factors (NtFUL1, NtSEP1, NtSEP2, NtSEP3), which are presumably involved in the regulation of transcription of the studied metabolic genes. These data suggest that partial knockout of NtPHO1-L1 alters the functional activity of tobacco starch phosphorylase. This, in turn, may influence the coordinated activity of starch catabolism enzymes, as well as chlorophyll and carotenoid synthesis enzymes, possibly through differential expression of MADS-box genes. The results highlight the critical regulatory role of plastid starch phosphorylase in transient starch metabolism and in stimulating plant photosynthesis.

Asiaticoside ameliorates type 2 diabetes mellitus in rats by modulating carbohydrate metabolism and regulating insulin signaling

Objective: To evaluate the effect of asiaticoside on streptozotocin (STZ) and nicotinamide (NAD)-induced carbohydrate metabolism abnormalities and deregulated insulin signaling pathways in rats. Methods: Asiaticoside (50 and 100 mg/kg body weight) was administered to STZ-NAD-induced diabetic rats for 45 days, and its effects on hyperglycaemic, carbohydrate metabolic, and insulin signaling pathway markers were examined. Results: Asiaticoside increased insulin production, lowered blood glucose levels, and enhanced glycolysis by improving hexokinase activity and suppressing glucose-6-phosphatase and fructose-1,6-bisphosphatase activities. Abnormalities in glycogen metabolism were mitigated by increasing glycogen synthase activity and gluconeogenesis was decreased by decreasing glycogen phosphorylase activity. Furthermore, asiaticoside upregulated the mRNA expressions of IRS-1, IRS-2, and GLUT4 in STZ-NAD-induced diabetic rats and restored the beta cell morphology to normal. Conclusions: Asiaticoside has the potential to ameliorate type 2 diabetes by improving glycolysis, gluconeogenesis, and insulin signaling pathways.

Suppression of Plastidial Glucan Phosphorylase (PHO1) Increases Drought Tolerance in Potato (Solanum tuberosum L.)

Glucan phosphorylase is present in plants in two isozymes, namely, a plastidial isoform (PHO1) and a cytosolic isoform (PHO2), and is involved in starch-related carbohydrate metabolism. The aim of this study was to determine whether mutations in the genes encoding glucan phosphorylase caused these plants to have increased resistance to short-term drought. One of the strategies plants use to defend themselves against drought stress is to change their starch content, which may be due to changes in glucan phosphorylase activity. In our greenhouse pot experiment, we used potato leaves from wild-type plants and transgenic mutant lines with reduced expression of genes encoding both PHO isozymes. The plants were exposed to drought or were grown under optimal conditions. A lack of water strongly affected the water saturation deficit (WSD) and leaf protein content. The activity of the plastidial glucan phosphorylase isoform (PHO1) in mutant plants increased under drought stress, in contrast to its activity in wild-type plants. After analyzing several physiological parameters, we found that suppressed expression of the gene encoding one of the subunits of plastidial glucan phosphorylase, PHO1a, resulted in increased tolerance to drought in potatoes.

Does sex matter in the cheetah? Insights into the skeletal muscle of the fastest land animal.

The cheetah is considered the fastest land animal, but studies on their skeletal muscle properties are scarce. Vastus lateralis biopsies, obtained from male and female cheetahs as well as humans, were analysed and compared for fibre type and size, and metabolism. Overall, cheetah muscle had predominantly type IIX fibres, which was confirmed by the myosin heavy chain isoform content (mean±s.d. type I: 17±8%, type IIA: 21±6%, type IIX: 62±12%), whereas human muscle contained predominantly type I and IIA fibres (type I: 49±14%, type IIA: 43±8%, type IIX: 7±7%). Cheetahs had smaller fibres than humans, with larger fibres in the males compared with their female counterparts. Citrate synthase (16±6 versus 28±7 µmolmin-1g-1 protein, P<0.05) and 3-hydroxyacyl co-enzyme A dehydrogenase (30±11 versus 47±15 µmolmin-1g-1 protein, P<0.05) activities were lower in cheetahs than in humans, whereas lactate dehydrogenase activity was 6 times higher in cheetahs (2159±827 versus 382±161 µmolmin-1g-1 protein, P<0.001). The activities of creatine kinase (4765±1828 versus 6485±1298, P<0.05 µmolmin-1g-1 protein) and phosphorylase (111±29 versus 216±92 µmolmin-1g-1 protein) were higher in humans, irrespective of the higher type IIX fibres in cheetahs. Superoxide dismutase and catalase, markers of antioxidant capacity, were higher in humans, but overall antioxidant capacity was higher in cheetahs. To conclude, fibre type, fibre size and metabolism differ between cheetahs and humans, with limited differences between the sexes.

The Role of Patiral Hormones in Metabolism

After the removal of the pancreas and during its hypofunction, a severe and difficult-to-treat disease called diabetes and sugary urine is observed in humans and animals. Under the influence of glucagon, the process of converting glycogen into glucose begins to take an active form in the liver and some other organs. Glucagon helps to increase the amount of glucose in the blood due to the activation of phosphorylase, which is involved in the breakdown of glycogen in the presence of glucose. Different animals have different sensitivity to glucagon. Glucagon affects fat metabolism and stimulates the breakdown of fat in adipose tissue.

Hypoglycemic Action of Glycocar on Insulin and Glucose Metabolism In Vivo

Background: Diabetes mellitus, particularly type 2, presents a growing global health challenge, with an estimated 700 million people expected to be affected by 2045. The disease is characterized by insulin resistance and impaired insulin secretion, necessitating effective treatments. This study aimed to explore the hypoglycemic mechanisms of Glykokar, a herbal formulation, in rats with alloxan-induced diabetes. The objective of this study was to investigate the hypoglycemic mechanisms of Glykokar, a herbal formulation. Methods: Eighteen rats with alloxan-induced diabetes were divided into groups receiving Glykokar at doses of 50 mg/kg or 100 mg/kg, and a control group receiving saline. The study measured the effects of Glykokar on C-peptide levels, glycogen content in liver and muscle, and the activity of hexokinase and phosphorylase enzymes over 7 and 14 days. Results: Results demonstrated that Glykokar significantly increased C-peptide levels, with the 100 mg/kg dose showing the greatest effect, enhancing C-peptide by 87.5% on day 14 compared to controls. Glycogen content in liver and muscle tissues was also elevated, particularly at the 100 mg/kg dose, which increased liver glycogen by 86% and muscle glycogen by 50%. Enzyme activity studies revealed that Glykokar reduced phosphorylase activity in diabetic muscle tissue and significantly boosted hexokinase and glucokinase activities, with the highest effects seen at the 100 mg/kg dose. Conclusion: The findings suggest that Glykokar’s hypoglycemic action is mediated through enhanced glucose metabolism in tissues, driven by increased enzymatic activity and glycogen storage. This study provides evidence for the potential of Glykokar as a therapeutic agent in managing hyperglycemia by improving glucose utilization and insulin secretion.

Structure-Based Virtual Screening, ADMET Properties Prediction and Molecular Dynamics Studies Reveal Potential Inhibitors of Mycoplasma pneumoniae HPrK/P.

Mycoplasma pneumoniae pneumonia (MPP) is a frequent cause of community-acquired pneumonia (CAP) in children. The incidence of childhood pneumonia caused by M. pneumoniae infection has been rapidly increasing worldwide. M. pneumoniae is naturally resistant to beta-lactam antibiotics due to its lack of a cell wall. Macrolides and related antibiotics are considered the optimal drugs for treating M. pneumoniae infection. However, clinical resistance to macrolides has become a global concern in recent years. Therefore, it is imperative to urgently identify new targets and develop new anti-M. pneumoniae drugs to treat MMP. Previous studies have shown that deficiencies in HPrK/P kinase or phosphorylase activity can seriously affect carbon metabolism, growth, morphology, and other cellular functions of M. pneumoniae. To identify potential drug development targets against M. pneumoniae, this study analyzed the sequence homology and 3D structure alignment of M. pneumoniae HPrK/P. Through sequence and structure analysis, we found that HPrK/P lacks homologous proteins in the human, while its functional motifs are highly conserved in bacteria. This renders it a promising candidate for drug development. Structure-based virtual screening was then used to discover potential inhibitors among 2614 FDA-approved drugs and 948 bioactive small molecules for M. pneumoniae HPrK/P. Finally, we identified three candidate drugs (Folic acid, Protokylol and Gluconolactone) as potential HPrK/P inhibitors through molecular docking, molecular dynamics (MDs) simulations, and ADMET predictions. These drugs offer new strategies for the treatment of MPP.

Inhibition of pyruvate dehydrogenase accelerates anaerobic glycolysis under postmortem simulating conditions

This research aimed to explore the potential influence of mitochondria on the rate of anaerobic glycolysis. We hypothesized that mitochondria could reduce the rate of anaerobic glycolysis and pH decline by metabolizing a portion of glycolytic pyruvate. We utilized an in vitro model and incorporated CPI-613 and Avidin to inhibit pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC), respectively. Four treatments were tested: 400 μM CPI-613, 1.5 U/ml Avidin, 400 μM CPI-613 + 1.5 U/ml Avidin, or control. Glycolytic metabolites and pH of the in vitro model were evaluated throughout a 1440-min incubation period. CPI-613-containing treatments, with or without Avidin, decreased pH levels and increased glycogen degradation and lactate accumulation compared to the control and Avidin treatments (P < 0.05), indicating increased glycolytic flux. In a different experiment, two treatments, 400 μM CPI-613 or control, were employed to track the fates of pyruvate using [13C6]glucose. CPI-613 reduced the contribution of glucose carbon to tricarboxylic acid cycle intermediates compared to control (P < 0.05). To test whether the acceleration of acidification in reactions containing CPI-613 was due to an increase in the activity of key enzymes of glycogenolysis and glycolysis, we evaluated the activities of glycogen phosphorylase, phosphofructokinase, and pyruvate kinase in the presence or absence of 400 μM CPI-613. The CPI-613 treatment did not elicit an alteration in the activity of these three enzymes. These findings indicate that inhibiting PDH increases the rate of anaerobic glycolysis and pH decline, suggesting that mitochondria are potential regulators of postmortem metabolism.

Five Weeks of Sprint Interval Training Improve Muscle Glycolytic Content and Activity But Not Time to Task Failure in Severe-Intensity Exercise.

This study examined the impact of a 5-wk sprint interval training (SIT) intervention on time to task failure (TTF) during severe-intensity constant work rate (CWR) exercise, as well as in glycolytic enzymatic content and activity, and glycogen content. Fourteen active males were randomized into either a SIT group ( n = 8) composed of 15 SIT sessions over 5 wk, or a control group ( n = 6). At pretraining period, participants performed i) ramp incremental test to measure the cardiorespiratory function; ii) CWR cycling TTF at 150% of the power output (PO) at the respiratory compensation point (RCP-PO) with muscle biopsies at rest and immediately following task failure. After 5 wk, the same evaluations were repeated (i.e., exercise intensities matched to current training status), and an additional cycling CWR matched to pretraining 150% RCP-PO was performed only for TTF evaluation. The content and enzymatic activity of glycogen phosphorylase (GPhos), hexokinase (HK), phosphofructokinase (PFK), and lactate dehydrogenase (LDH), as well as the glycogen content, were analyzed. Content of monocarboxylate transporter isoform 4 (MCT4) and muscle buffering capacity were also measured. Despite improvements in total work performed at CWR posttraining, no differences were observed for TTF. The GPhos, HK, PFK, and LDH content and activity, and glycogen content also improved after training only in the SIT group. Furthermore, the MCT4 concentrations and muscle buffering capacity were also improved only for the SIT group. However, no difference in glycogen depletion was observed between groups and time. Five weeks of SIT improved the glycolytic pathway parameters and total work performed; however, glycogen depletion was not altered during CWR severe-intensity exercise, and TTF remained similar.

Monocarboxylate transporter 4 deficiency enhances high-intensity interval training-induced metabolic adaptations in skeletal muscle.

High-intensity exercise stimulates glycolysis, subsequently leading to elevated lactate production within skeletal muscle. While lactate produced within the muscle is predominantly released into the circulation via the monocarboxylate transporter 4 (MCT4), recent research underscores lactate's function as an intercellular and intertissue signalling molecule. However, its specific intracellular roles within muscle cells remains less defined. In this study, our objective was to elucidate the effects of increased intramuscular lactate accumulation on skeletal muscle adaptation to training. To achieve this, we developed MCT4 knockout mice and confirmed that a lack of MCT4 indeed results in pronounced lactate accumulation in skeletal muscle during high-intensity exercise. A key finding was the significant enhancement in endurance exercise capacity at high intensities when MCT4 deficiency was paired with high-intensity interval training (HIIT). Furthermore, metabolic adaptations supportive of this enhanced exercise capacity were evident with the combination of MCT4 deficiency and HIIT. Specifically, we observed a substantial uptick in the activity of glycolytic enzymes, notably hexokinase, glycogen phosphorylase and pyruvate kinase. The mitochondria also exhibited heightened pyruvate oxidation capabilities, as evidenced by an increase in oxygen consumption when pyruvate served as the substrate. This mitochondrial adaptation was further substantiated by elevated pyruvate dehydrogenase activity, increased activity of isocitrate dehydrogenase - the rate-limiting enzyme in the TCA cycle - and enhanced function of cytochrome c oxidase, pivotal to the electron transport chain. Our findings provide new insights into the physiological consequences of lactate accumulation in skeletal muscle during high-intensity exercises, deepening our grasp of the molecular intricacies underpinning exercise adaptation. KEY POINTS: We pioneered a unique line of monocarboxylate transporter 4 (MCT4) knockout mice specifically tailored to the ICR strain, an optimal background for high-intensity exercise studies. A deficiency in MCT4 exacerbates the accumulation of lactate in skeletal muscle during high-intensity exercise. Pairing MCT4 deficiency with high-intensity interval training (HIIT) results in a synergistic boost in high-intensity exercise capacity, observable both at the organismal level (via a treadmill running test) and at the muscle tissue level (through an ex vivo muscle contractile function test). Coordinating MCT4 deficiency with HIIT enhances both the glycolytic enzyme activities and mitochondrial capacity to oxidize pyruvate.

Cryo-EM structures of Mycobacterium tuberculosis polynucleotide phosphorylase suggest a potential mechanism for its RNA substrate degradation

As one of the oldest infectious diseases in the world, tuberculosis (TB) is the second most deadly infectious disease after COVID-19. Tuberculosis is caused by Mycobacterium tuberculosis (Mtb), which can attack various organs of the human body. Up to now, drug-resistant TB continues to be a public health threat. Pyrazinamide (PZA) is regarded as a sterilizing drug in the treatment of TB due to its distinct ability to target Mtb persisters. Previously we demonstrated that a D67N mutation in Mycobacterium tuberculosis polynucleotide phosphorylase (MtbPNPase, Rv2783c) confers resistance to PZA and Rv2783c is a potential target for PZA, but the mechanism leading to PZA resistance remains unclear. To gain further insight into the MtbPNPase, we determined the cryo-EM structures of apo Rv2783c, its mutant form and its complex with RNA. Our studies revealed the Rv2783c structure at atomic resolution and identified its enzymatic functional groups essential for its phosphorylase activities. We also investigated the molecular mechanisms underlying the resistance to PZA conferred by the mutation. Our research findings provide structural and functional insights enabling the development of new anti-tuberculosis drugs.

Evolution of Phosphorylase Activity in an Ancestral Glycosyltransferase.

The reconstruction of ancestral sequences can offer a glimpse into the fascinating process of molecular evolution by exposing the adaptive pathways that shape the proteins found in nature today. Here, we track the evolution of the carbohydrate-active enzymes responsible for the synthesis and turnover of mannogen, a critical carbohydrate reserve in Leishmania parasites. Biochemical characterization of resurrected enzymes demonstrated that mannoside phosphorylase activity emerged in an ancestral bacterial mannosyltransferase, and later disappeared in the process of horizontal gene transfer and gene duplication in Leishmania. By shuffling through plausible historical sequence space in an ancestral mannosyltransferase, we found that mannoside phosphorylase activity could be toggled on through various combinations of mutations at positions outside of the active site. Molecular dynamics simulations showed that such mutations can affect loop rigidity and shield the active site from water molecules that disrupt key interactions, allowing α-mannose 1-phosphate to adopt a catalytically productive conformation. These findings highlight the importance of subtle distal mutations in protein evolution and suggest that the vast collection of natural glycosyltransferases may be a promising source of engineering templates for the design of tailored phosphorylases.